Kristensen DT, Brondum RF, Orskov AD, Marcher CW, et al. Venetoclax-based therapy for relapsed or refractory acute myeloid leukaemia following intensive induction chemotherapy. Eur J Haematol 2023;111:573-582.
PMID: 37489268